Skip to content 
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, Genomics & Biotechnology Companies), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified. more
| Time Frame | GNOM | S&P500 |
|---|---|---|
| 1-Week Return | -3.7% | 0.01% |
| 1-Month Return | 18.22% | 3.54% |
| 3-Month Return | 29.04% | 10.58% |
| 6-Month Return | 19.59% | 8.03% |
| 1-Year Return | 57.01% | 20.06% |
| 3-Year Return | 16.09% | 70.98% |
| 5-Year Return | -40.52% | 71.89% |
| 10-Year Return | -7.86% | 252.66% |
| Stock name | Ticker | Weight |
|---|---|---|
 GUARDANT HEALTH INC | GH | 6.06% |
 ILLUMINA INC | ILMN | 4.94% |
 TWIST BIOSCIENCE CORP | TWST | 4.72% |
 NATERA INC | NTRA | 4.41% |
 10X GENOMICS INC-CLASS A | TXG | 4.28% |
 MODERNA INC | MRNA | 4.17% |
 BIO-TECHNE CORP | TECH | 4.13% |
 VERACYTE INC | VCYT | 3.93% |
 VERTEX PHARMACEUTICALS INC | VRTX | 3.76% |
 BIOMARIN PHARMACEUTICAL INC | BMRN | 3.7% |
 LEGEND BIOTECH CORP-ADR | LEGN | 3.54% |
 QIAGEN N.V. | QGEN | 3.52% |
 ARROWHEAD PHARMACEUTICALS IN | ARWR | 3.51% |
 PRAXIS PRECISION MEDICINES I | PRAX | 3.27% |
 CRISPR THERAPEUTICS AG | CRSP | 3.21% |
 BIONTECH SE-ADR | BNTX | 2.86% |
 ULTRAGENYX PHARMACEUTICAL IN | RARE | 2.79% |
 BEAM THERAPEUTICS INC | BEAM | 2.69% |
 BILLIONTOONE INC CL A | BLLN | 2.22% |
 ELI LILLY & CO | LLY | 2.17% |
 UNIQURE NV | QURE | 2.09% |
 CARIS LIFE SCIENCES INC | CAI | 1.81% |
 GENSCRIPT BIOTECH CORP | 1548.HK | 1.78% |
 SAREPTA THERAPEUTICS INC | SRPT | 1.67% |
 GILEAD SCIENCES INC | GILD | 1.66% |
 GENEDX HOLDINGS CORP | WGS | 1.5% |
 ASTRAZENECA PLC | AZN.L | 1.49% |
 INTELLIA THERAPEUTICS INC | NTLA | 1.41% |
 STOKE THERAPEUTICS INC | STOK | 1.3% |
 CAREDX INC | CDNA | 1.16% |
 DANAHER CORP | DHR | 1.12% |
 BRISTOL-MYERS SQUIBB CO | BMY | 1.02% |
 VIR BIOTECHNOLOGY INC | VIR | 1.02% |
 WAVE LIFE SCIENCES LTD | WVE | 0.86% |
 PERSONALIS INC | PSNL | 0.86% |
 REGENXBIO INC | RGNX | 0.57% |
 MARAVAI LIFESCIENCES HLDGS-A | MRVI | 0.57% |
 MYRIAD GENETICS INC | MYGN | 0.45% |
 BENITEC BIOPHARMA INC | BNTC | 0.39% |
 BRUKER CORP | BRKR | 0.38% |
 PACIFIC BIOSCIENCES OF CALIF | PACB | 0.37% |
 FULGENT GENETICS INC | FLGT | 0.36% |
 ROCKET PHARMACEUTICALS INC | RCKT | 0.36% |
 AGILENT TECHNOLOGIES INC | A | 0.33% |
 PRIME MEDICINE INC | PRME | 0.32% |
 EDITAS MEDICINE INC | EDIT | 0.28% |
 QUEST DIAGNOSTICS INC | DGX | 0.26% |
 STANDARD BIOTOOLS INC | LAB | 0.25% |
 MESA LABORATORIES INC | MLAB | 0.24% |
 CARIBOU BIOSCIENCES INC | CRBU | 0.21% |
 OTHER PAYABLE & RECEIVABLES | OTHER.PAYABLE...RECEIVABLES | 0.03% |
 CASH | CASH | 0% |
| Sector | Weight |
|---|---|
|
Health care | 99.68% |
|
Information Technology | 0.32% |
Global X Genomics & Biotechnology ETF (GNOM) share price today is $56.65.
Yes, Indians can buy shares of Global X Genomics & Biotechnology ETF (GNOM) on Vested. To buy GNOM from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Global X Genomics & Biotechnology ETF (GNOM) on Vested. You can start investing in Global X Genomics & Biotechnology ETF (GNOM) with a minimum investment of $1.
The 52-week high price of Global X Genomics & Biotechnology ETF (GNOM) is $59.48. The 52-week low price of Global X Genomics & Biotechnology ETF (GNOM) is $33.57.
The stock symbol (or ticker) of Global X Genomics & Biotechnology ETF is GNOM.
Yes, you can setup SIP in Global X Genomics & Biotechnology ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of GNOM on the Vested app.
The expense ratio of Global X Genomics & Biotechnology ETF (GNOM) is 0.5%.
Link copied 
